Welcome to the conference call for analysts and investors for Infineon's 2026 Fiscal Second Quarter Results. Today's call will be hosted by Alexander Foltin, Executive Vice President, Finance, ...

Good afternoon. My name is Audrey, and I will be your conference operator today. At this time, I would like to welcome everyone to the Astera Labs First Quarter 2026 Earnings Conference Call.

Now, it’s worth noting Stock Advisor’s total average return is 981 % — a market-crushing outperformance compared to 205% for the S&P 500. Don't miss the latest top 10 list, available with Stock ...

World, the Sam Altman-backed digital identity project, has unveiled on Friday what it calls its most significant upgrade yet to World ID, positioning the system as “full-stack proof of human” ...

At a trendy venue near the San Francisco pier, Sam Altman’s verification project World celebrated its next evolution and rapid expansion of its ambitions. And it’s starting with Tinder. Tools for ...

My Alerts is a service for subscribers. Please login or subscribe in order to use My Alerts. Chinese state-owned offshore fabricator Offshore Oil Engineering Company (COOEC) has delivered the final ...

Forbes contributors publish independent expert analyses and insights. Desjah is an entertainment contributor, focusing on music. 15 years after its release on December 21, 2010, The Marathon is no ...

In the relentless churn of the daily news cycle, it’s easy to become consumed by “the issues” – be it climate change, health system collapse, or global conflict. That concern might prompt a one-off ...

Sam Altman’s iris-scanning, humanity-verifying World project announced at an event in San Francisco on Friday that Tinder users around the globe can now put a digital badge on their profiles signaling ...

Mr. Altman, who has faced criticism over OpenAI’s direction, has culled company projects and is trying to be more disciplined with strategy. Credit...Photo Illustration by Javier Palma; Source ...

Formation Bio CEO Ben Liu is convinced that drug discovery isn’t the bottleneck in getting medicines to market—it’s going through clinical trials. Now he’s raised some $615 million from top investors ...